Douglas L. Feinstein, PhD, University of Illinois at Chicago
Douglas L. Feinstein, PhD
The Feinstein laboratory studies novel approaches to reduce damage and inflammation in neurodegenerative diseases. Studies include analysis of disease progression in mouse models of Alzheimer's disease (AD) and multiple sclerosis (MS), in vitro studies using primary cultures of neurons and glial cells from wild type and transgenic mice, and analysis of the molecular events involved. Dr. Feinstein is involved in the design of early stage clinical trials for MS and AD.
Part of The Investigator's Annexe program.
